1. Testicular cancer survivors have shorter anogenital distance that is not increased by 1 year of testosterone replacement therapy. Issue 9 (5th July 2021) Authors: Priskorn, L; Kreiberg, M; Bandak, M; Lauritsen, J; Daugaard, G; Petersen, J H; Aksglaede, L; Juul, A; Jørgensen, N Journal: Human reproduction Issue: Volume 36:Issue 9(2021) Page Start: 2443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗